tiprankstipranks
ProMIS Neurosciences Inc. (PMN)
NASDAQ:PMN
US Market
PMN
ProMIS Neurosciences
RESEARCH TOOLSreports
Want to see PMN full AI Analyst Report?

ProMIS Neurosciences (PMN) Stock Forecast & Price Target

300 Followers
See the Price Targets and Ratings of:

PMN Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
ProMIS
Neurosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PMN Stock 12 Month Forecast

Average Price Target

$35.96
▲(194.79% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for ProMIS Neurosciences in the last 3 months. The average price target is $35.96 with a high forecast of $69.00 and a low forecast of $18.00. The average price target represents a 194.79% change from the last price of $12.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","70":"$70","21.25":"$21.3","37.5":"$37.5","53.75":"$53.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":69,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$69.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.964285714285715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.96</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,21.25,37.5,53.75,70],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.45,17.723076923076924,21.996153846153845,26.269230769230766,30.54230769230769,34.815384615384616,39.08846153846154,43.36153846153846,47.63461538461539,51.9076923076923,56.18076923076923,60.45384615384616,64.72692307692307,{"y":69,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.45,15.181868131868132,16.91373626373626,18.645604395604394,20.377472527472527,22.10934065934066,23.841208791208793,25.573076923076922,27.304945054945055,29.036813186813188,30.76868131868132,32.50054945054945,34.23241758241758,{"y":35.964285714285715,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.45,13.799999999999999,14.149999999999999,14.5,14.85,15.2,15.549999999999999,15.899999999999999,16.25,16.6,16.95,17.3,17.65,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.218,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.162,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.497,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.377,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.825,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.05,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.79,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.01,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.41,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.45,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$69.00Average Price Target$35.96Lowest Price Target$18.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on PMN
Boobalan Pachaiyappan
Roth MKM
Roth MKM
$30
Buy
145.90%
Upside
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Opko Health (NASDAQ: OPK), ProMIS Neurosciences (NASDAQ: PMN) and The Ensign Group (NASDAQ: ENSG)
Guggenheim Analyst forecast on PMN
Eddie Hickman
Guggenheim
Guggenheim
$35→$69
Buy
465.57%
Upside
Reiterated
07/28/26
ProMIS Neurosciences price target raised to $69 from $35 at GuggenheimProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
Maxim Group Analyst forecast on PMN
Jason McCarthy
Maxim Group
Maxim Group
$35
Buy
186.89%
Upside
Reiterated
07/28/26
PMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
Chardan Capital Analyst forecast on PMN
Keay Nakae
Chardan Capital
Chardan Capital
$20
Buy
63.93%
Upside
Initiated
07/26/26
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (Other OTC: RAFLF), ProMIS Neurosciences (NASDAQ: PMN) and Chugai Pharmaceutical Co (Other OTC: CHGCF)
H.C. Wainwright Analyst forecast on PMN
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$18
Buy
47.54%
Upside
Reiterated
07/15/26
Buy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
Cantor Fitzgerald Analyst forecast on PMN
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
$39.75
Buy
225.82%
Upside
Initiated
06/29/26
Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (NASDAQ: PMN) and Icon (NASDAQ: ICLR)
Brookline Capital Markets Analyst forecast on PMN
Unknown Analyst
Brookline Capital Markets
Not Ranked
Brookline Capital Markets
$40
Buy
227.87%
Upside
Initiated
05/20/26
ProMIS Neurosciences initiated with a Buy at BrooklineProMIS Neurosciences initiated with a Buy at Brookline
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on PMN
Boobalan Pachaiyappan
Roth MKM
Roth MKM
$30
Buy
145.90%
Upside
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Opko Health (NASDAQ: OPK), ProMIS Neurosciences (NASDAQ: PMN) and The Ensign Group (NASDAQ: ENSG)
Guggenheim Analyst forecast on PMN
Eddie Hickman
Guggenheim
Guggenheim
$35→$69
Buy
465.57%
Upside
Reiterated
07/28/26
ProMIS Neurosciences price target raised to $69 from $35 at GuggenheimProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
Maxim Group Analyst forecast on PMN
Jason McCarthy
Maxim Group
Maxim Group
$35
Buy
186.89%
Upside
Reiterated
07/28/26
PMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
Chardan Capital Analyst forecast on PMN
Keay Nakae
Chardan Capital
Chardan Capital
$20
Buy
63.93%
Upside
Initiated
07/26/26
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (Other OTC: RAFLF), ProMIS Neurosciences (NASDAQ: PMN) and Chugai Pharmaceutical Co (Other OTC: CHGCF)
H.C. Wainwright Analyst forecast on PMN
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$18
Buy
47.54%
Upside
Reiterated
07/15/26
Buy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
Cantor Fitzgerald Analyst forecast on PMN
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
$39.75
Buy
225.82%
Upside
Initiated
06/29/26
Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (NASDAQ: PMN) and Icon (NASDAQ: ICLR)
Brookline Capital Markets Analyst forecast on PMN
Unknown Analyst
Brookline Capital Markets
Not Ranked
Brookline Capital Markets
$40
Buy
227.87%
Upside
Initiated
05/20/26
ProMIS Neurosciences initiated with a Buy at BrooklineProMIS Neurosciences initiated with a Buy at Brookline
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ProMIS Neurosciences

3 Months
Ram SelvarajuH.C. Wainwright
Success Rate
4/5 ratings generated profit
80%
Average Return
+65.96%
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +65.96% per trade.
1 Year
Ram SelvarajuH.C. Wainwright
Success Rate
5/5 ratings generated profit
100%
Average Return
+40.62%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.62% per trade.
2 Years
Ram SelvarajuH.C. Wainwright
Success Rate
5/5 ratings generated profit
100%
Average Return
+41.94%
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PMN Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
2
4
6
11
Buy
0
0
0
0
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
2
4
6
13
In the current month, PMN has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PMN average Analyst price target in the past 3 months is 35.96.
Each month's total comprises the sum of three months' worth of ratings.

PMN Financial Forecast

PMN Earnings Forecast

Next quarter’s earnings estimate for PMN is -$1.41 with a range of -$2.09 to -$1.01. The previous quarter’s EPS was -$1.26. PMN beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year PMN has Outperformed its overall industry.
Next quarter’s earnings estimate for PMN is -$1.41 with a range of -$2.09 to -$1.01. The previous quarter’s EPS was -$1.26. PMN beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year PMN has Outperformed its overall industry.

PMN Sales Forecast

Next quarter’s sales forecast for PMN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PMN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year PMN has Performed in-line its overall industry.
Next quarter’s sales forecast for PMN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PMN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year PMN has Performed in-line its overall industry.

PMN Stock Forecast FAQ

What is PMN’s average 12-month price target, according to analysts?
Based on analyst ratings, ProMIS Neurosciences Inc.’s 12-month average price target is 35.96.
    What is PMN’s upside potential, based on the analysts’ average price target?
    ProMIS Neurosciences Inc. has 194.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PMN a Buy, Sell or Hold?
          ProMIS Neurosciences Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is ProMIS Neurosciences Inc.’s price target?
            The average price target for ProMIS Neurosciences Inc. is 35.96. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $69.00 ,the lowest forecast is $18.00. The average price target represents 194.79% Increase from the current price of $12.2.
              What do analysts say about ProMIS Neurosciences Inc.?
              ProMIS Neurosciences Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of PMN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.